Medtronic issues €3.0B in senior notes across four tranches; net proceeds ~€2.97B for general corporate purposes

Medtronic plc

Issued €850M 3.650% notes due 2029, €850M 3.875% due 2036, €600M 4.150% due 2043, €700M 4.150% due 2053.
Net proceeds of ~€2.97B after underwriting discount and expenses.
Proceeds to be used for general corporate purposes, may include repayment of commercial paper and other debt.
Notes fully and unconditionally guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A.
Financial impact already reflected in FY2025 adjusted EPS guidance announced May 23, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.